No association of inducible nitric oxide synthase gene (NOS2A) to multiple sclerosis

Journal of Neurology

Volumn 250, Issue 5, 2003, Pages 598-600

  Blanco, Yolanda ^a   Yagüe, Jordi ^b   Graus, Francesc ^a   Saiz, Albert ^a  

^a HOSPITAL CLÍNIC   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Multiple sclerosis; Nitric oxide; NOS2A promoter

Indexed keywords

NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; GENE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NOS2A GENE; PRIORITY JOURNAL; PROMOTER REGION;

ADULT; ANALYSIS OF VARIANCE; CHI-SQUARE DISTRIBUTION; CONFIDENCE INTERVALS; CROSS-SECTIONAL STUDIES; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; ODDS RATIO; POLYMORPHISM, GENETIC;

EID: 0037903294     PISSN: 03405354     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00415-003-1047-7     Document Type: Article

References (15)

1. Bellamy R, Hill AVS (1997) A biallelic tetranucleotide repeat in the promoter of the human inducible nitric oxide synthase gene. Clin Genet 52:192-193
2. Bloch KD, Wolfram JR, Brown DM, Roberts JD Jr, Zapol DG, Lepore JJ, Filippov G, Thomas JE, Jacob HJ, Bloch DB (1995) Three members of the nitric oxide synthase gene family (NOS2A, NOS2B, and NOS2C) colocalize to human chromosome 17. Genomics 27:526-530
3. Giovannoni G (1998) Cerebrospinal fluid and serum nitric oxide metabolites in patients with multiple sclerosis. Multiple sclerosis 4:27-30
4. Hillert J, Masterman T (2001) The genetics of multiple sclerosis. In: Cook SD (ed) Handbook of multiple sclerosis. Marcel Dekker, New York, pp 33-66
5. Kuokkanen S, Gschwend M, Rioux JD, Daly MJ, Terwilliger JD, Tienari PJ, Wikstrom J, Palo J, Stein LD, Hudson TJ, Lander ES, Peltonen L (1997) Genomewide scan of MS in Finnish multiplex families. Am J Hum Genet 61:1379-1387
6. Liu JSH, Zhao M-L, Brosnan CF, Lee SC (2001) Expression of inducible nitric oxide synthase and nitrotyrosine in multiple sclerosis lesions. Am J Pathol 158:2057-2066
7. Lublin FD, Reingold SC (1996) Defining the clinical course of multiple sclerosis: results of an international survey. Neurology 46:907-911
8. Modin H, Dai Y, Masterman T, Svejgaard A, Sorensen PS, Oturai A, Ryder LP, Spurkland A, Vartdal F, Laaksonen M, Sandberg-Wollheim M, Myhr KM, Nyland H, Hillert J (2001) No linkage or association of the nitric oxide synthase genes to multiple sclerosis. J Neuroimm 119:95-100
9. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, Johnson KP, Sibley WA, Silberberg DH, Tourtellotte WW (1983) New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983 13:227-231
10. Sawcer S, Jones HB, Feakes R, Gray J, Smadon N, Chataway J, Robertson N, Clayton D, Goodfellow PN, Compston A (1996). Nat Genet 13:464-468
11. Schrijver HM, Crusius JBA, Uitdehaag BMJ, García González MA, Kostense PJ, Polman CH, Peña AS (1999) Association of interleukin-1 β and interleukin-1 receptor antagonist genes with disease severity in MS. Neurology 52:595-599
12. Smith KJ, Kapoor R, Hall SM, Davies M (2001) Electrically active axons degenerate when exposed to nitric oxide. Ann Neurol 49:470-476
13. Terwilliger JD (1995) A powerful likelihood method for the analysis of linkage disequilibrium between trait loci and one or more polymorphic marker loci. Am J Hum Genet 56:777-787
14. Warpeha KM, Xu W, Liu L, Charles IG, Patterson CC, Ah-Fat F, Harding S, Hart PM, Chakravarthy U, Hughes AE (1999) Genotyping and functional analysis of a polymorphic (CCTTT)n repeat of NOS2A in diabetic retinopathy. FASEB 13:1825-1832
15. Xu W, Liu L, Emson PC, Harrington CR, Charles IG (1997) Evolution of a homopurine-homopyrimidine pentanucleotide repeat sequence upstream of the human inducible nitric oxide synthase gene. Gene 204:165-170